Personalized approaches to prevent non-communicable diseases in Kazakhstan

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on enhancing personalized and preventive care for non-communicable diseases (NCDs) in Kazakhstan by investigating epigenetic factors and utilizing machine learning to predict biological age and reproductive function. The study involves DNA analysis to develop tailored health improvement recommendations for participants. By examining the relationship between DNA methylation and various health conditions, the research aims to provide insights into effective prevention strategies for cardiovascular diseases, type 2 diabetes, chronic respiratory diseases, obesity, and chronic kidney diseases.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults aged 18 to 69 years.
* Residents of 17 regions of Kazakhstan.
* Willingness to participate and provide informed consent.

Exclusion Criteria:

* Age less than 18 years old or over 69 years old.
* Failure to provide informed consent or incomplete participation in data collection procedures.

Where it's running

• Asfendiyarov Kazakh National Medical University
  Almaty, Kazakhstan, Kazakhstan Recruiting

Study contacts

• Study coordinator: Ildar Fakhradiyev, Ph.D
• Email: fakhradiyev.i@kaznmu.kz
• Phone: +7 (727) 338 7090

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Health for Hungary: Long-term blood and health data collection to study aging and disease onset

  This study tests whether routine blood tests plus advanced molecular analyses can help detect the early stages of non-communicable diseases in adults over 40.

  Recruiting at 21 sites Center for Molecular Fingerprinting Research Nonprofit LLC · Balatonfüred and 32 other locations · NCT07743021

• Acute Blood Flow Restriction Walking in Type 2 Diabetes

  This study tests whether adding blood flow restriction to treadmill walking affects immune cells in adults with type 2 diabetes.

  Recruiting University of British Columbia · Kelowna, British Columbia · NCT07928531

• Chronic Respiratory Disease Participant Engagement

  This study tests whether adults with long-term lung conditions can get comfortable with a clinical trials unit and research team before joining future trials.

  Recruiting Richmond Pharmacology Limited · London · NCT07924462

• Continuous Glucose Monitoring in Type 2 Diabetes Not on Insulin

  This study tests whether using a continuous glucose monitoring system helps people with type 2 diabetes who aren’t using insulin to improve blood sugar control and quality of life.

  Recruiting Medical University of Bialystok · Bialystok · NCT07919236

• Differentiating heart disease in autoimmune vs. type 2 diabetes

  This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.

  Recruiting University of Roma La Sapienza · Rome, Roma · NCT07911007

• Tailored digital support to cut sedentary time in long-term cardiac rehab

  In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.

  Recruiting University of Lisbon · Lisbon, Lisbon District · NCT07910812

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.